It has been another busy week for Australia's top brokers. This has led to the release of a large number of broker notes.
Three broker buy ratings that you might want to know more about are summarised below. Here's why brokers think these ASX shares are in the buy zone:
Image source: Getty Images
Lovisa Holdings Ltd (ASX: LOV)
According to a note out of Morgans, its analysts have retained their add rating and lifted their price target on this fashion jewellery retailer's shares to $24.00. This follows the release of a half year result which impressed the broker. Morgans felt Lovisa's 21.5% like for like sales growth was remarkable. Overall, it believes Lovisa could become a global force and one of the biggest success stories in Australian retail. The Lovisa share price is trading at $19.97 on Friday afternoon.
NextDC Ltd (ASX: NXT)
A note out of Macquarie reveals that its analysts have retained their outperform rating but trimmed their price target on this data centre operator's shares to $13.90. Macquarie was pleased with NextDC's half year results, which came in ahead of its estimates. It was also pleased to see management upgrade its FY 2022 guidance and appears confident in the company's growth trajectory. The NextDC share price is fetching $10.65 on Friday.
Ramsay Health Care Limited (ASX: RHC)
Analysts at Citi have upgraded this private healthcare operator's shares to a buy rating with a $64.00 price target. This follows the release of a half year result that was largely in line with expectations. Overall, the broker believes that Ramsay Health Care's shares offer a lot of value for money following recent weakness and upgrades them to a buy rating. The Ramsay Health Care share price is trading at $64.38 on Friday.
